Research shows bulevirtide and peginterferon alfa-2a best treatment for chronic hepatitis D
The combination of bulevirtide plus peginterferon alfa-2a is superior to bulevirtide monotherapy for achieving undetectable hepatitis D virus (HDV) RNA level at 24 weeks after the end of treatment in patients with chronic ...
Jun 10, 2024
0
0